Search

everythinglearnresearchcommunity

for

Search:↓

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Tofacitinib taken by mouth helps treat hair loss in children.

New drug shows promise for better hair growth in baldness treatment.

Finasteride can prevent breast cancer progression by blocking progesterone's conversion to a cancer-promoting hormone.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Five FDA-approved drugs may help block COVID-19 virus entry.

Flexible bioelectronics show promise in non-invasive cancer detection and treatment but need improvements in stability and effectiveness.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Third booster shots enhance the immune system's response to the COVID-19 virus.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

CRISPR-Cas9 allows precise DNA editing but raises ethical concerns about modifying human embryos.

Cepharanthine shows promise as a COVID-19 treatment.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Vaccination is crucial for public health, but anti-vaccine movements are a concern.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Six existing drugs may help block virus entry in COVID-19.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Multiomics is revolutionizing biology by enabling breakthroughs in research and disease diagnosis.

iPSCs are promising for studying and treating COVID-19.

Two girls experienced temporary hair loss after getting the HPV vaccine, which may be related to the vaccine.

COVID-19 vaccination may cause kidney inflammation, treatable with steroids and Cellcept.